Achieve Life Sciences, Inc.
ACHV· Nasdaq
ACHVAchieve Life Sciences, Inc.
Filed Nov 9, 2017 · 10-Q · 40 days after period end · 0001564590-17-023285
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Net Income | -$6.47M | -$268.00K | -$4.55M | -$4.91M |
| EPS Diluted | -$8.95 | -$12.62 | $0.16 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 9, 2017 · 40 d after period end
